Evidence map›Paper›PMID 29491302›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Severe and Recurrent Hypoglycemia Caused by Garenoxacin in a Patient not Taking Hypoglycemic Drugs.

Manabu Kondo, Yuka Miyoshi, Kohji Tarumoto, Norie Hirayama, Takahiro Sasaki, Kohji Yamashita, Susumu Yamashita, Katsuhiro Hatao

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Manabu KondoDepartment of Endocrinology and Hematology, Tokuyama Central Hospital, Japan.
Yuka MiyoshiDepartment of Endocrinology and Hematology, Tokuyama Central Hospital, Japan.
Kohji TarumotoDepartment of Emergency and Critical Care Medicine, Tokuyama Central Hospital, Japan.
Norie HirayamaDepartment of Pharmacy, Tokuyama Central Hospital, Japan.
Takahiro SasakiDepartment of Endocrinology and Hematology, Tokuyama Central Hospital, Japan.
Kohji YamashitaDepartment of Endocrinology and Hematology, Tokuyama Central Hospital, Japan.
Susumu YamashitaDepartment of Emergency and Critical Care Medicine, Tokuyama Central Hospital, Japan.
Katsuhiro HataoDepartment of Endocrinology and Hematology, Tokuyama Central Hospital, Japan.
Tokuyama (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quinolones are known to induce hypoglycemia, although there is no written report of garenoxacin-induced hypoglycemia. We herein report a case of garenoxacin-induced hypoglycemia in a patient not taking hypoglycemic drugs. An 89-year-old Japanese woman with type 2 diabetes and chronic renal insufficiency requiring hemodialysis was admitted to the emergency department in a comatose state. Her serum glucose measured 1 mg/dL on arrival. The patient had not taken any hypoglycemic drugs recently and had never experienced a hypoglycemic episode. She had received a four-day course of garenoxacin treatment before the emergency admission. Clinicians should therefore recognize the potential risk of hypoglycemia during garenoxacin therapy.

Indexed as

Aged, 80 and overAnti-Bacterial AgentsComaDiabetes Mellitus, Type 2FemaleFluoroquinolonesHumansHypoglycemiaKidney Failure, ChronicRenal DialysisAnti-Bacterial AgentsFluoroquinolonesgarenoxacinhypoglycemiaquinolonesrenal insufficiency

Identifiers

PMID29491302
PMCPMC6096026
OpenAlexW2788035298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.